<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35349010</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1573-7403</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
              <Day>29</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pituitary</Title>
          <ISOAbbreviation>Pituitary</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Endocrine disorders after primary gamma knife radiosurgery for pituitary adenomas: A systematic review and meta-analysis.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11102-022-01219-x</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Gamma Knife radiosurgery (GKRS) is feasible for pituitary adenomas, but post-surgery GKRS may cause severe hormone deficits. We reviewed the literature on primary GKRS for pituitary adenoma focusing on radiation-induced hormone deficiencies.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, Web-of-Science, Scopus, and Cochrane were searched upon the PRISMA guidelines to include studies describing primary GKRS for pituitary adenomas. Pooled-rates of GKRS-induced hormone deficiencies and clinical-radiological responses were analyzed with a random-effect model meta-analysis.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We included 24 studies comprising 1381 patients. Prolactinomas were the most common (34.2%), and 289 patients had non-functioning adenomas (20.9%). Median tumor volume was 1.6cm<sup>3</sup> (range, 0.01-31.3), with suprasellar extension and cavernous sinus invasion detected in 26% and 31.1% cases. GKRS was delivered with median marginal dose 22.6 Gy (range, 6-49), maximum dose 50 Gy (range, 25-90), and isodose line 50% (range, 9-100%). Median maximum point doses were 9 Gy (range, 0.5-25) to the pituitary stalk, 7 Gy (range, 1-38) to the optic apparatus, and 5 Gy (range, 0.4-12.3) to the optic chiasm. Pooled 5 year rates of endocrine normalization and local tumor control were 48% (95%CI 45-51%) and 97% (95%CI 95-98%). 158 patients (11.4%) experienced endocrinopathies at a median of 45 months (range, 4-187.3) after GKRS, with pooled 5-year rates of 8% (95%CI 6-9%). GKRS-induced hormone deficiencies comprised secondary hypothyroidism (42.4%) and hypogonadotropic hypogonadism (33.5%), with panhypopituitarism reported in 31 cases (19.6%).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Primary GKRS for pituitary adenoma may correlate with lower rates of radiation-induced hypopituitarism (11.4%) than post-surgery GKRS (18-32%). Minimal doses to normal pituitary structures and long-term endocrine follow-up are of primary importance.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Palmisciano</LastName>
            <ForeName>Paolo</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0003-0711-3975</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, University of Cincinnati, Cincinnati, OH, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ogasawara</LastName>
            <ForeName>Christian</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>John A. Burns School of Medicine, University of Hawai'i, Honolulu, HI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ogasawara</LastName>
            <ForeName>Maya</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>University of California, Berkeley, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ferini</LastName>
            <ForeName>Gianluca</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, REM Radioterapia srl, Viagrande, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Scalia</LastName>
            <ForeName>Gianluca</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, Highly Specialized Hospital of National Importance "Garibaldi", Catania, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Haider</LastName>
            <ForeName>Ali S</ForeName>
            <Initials>AS</Initials>
            <AffiliationInfo>
              <Affiliation>Texas A&amp;M University College of Medicine, Houston, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bin Alamer</LastName>
            <ForeName>Othman</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Salvati</LastName>
            <ForeName>Maurizio</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, IRCCS, Sapienza University of Rome, NeuromedPozzilli, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Umana</LastName>
            <ForeName>Giuseppe E</ForeName>
            <Initials>GE</Initials>
            <Identifier Source="ORCID">0000-0002-1573-431X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, Trauma Center, Gamma Knife Center, Cannizzaro Hospital, Via Messina 829, 95126, Catania, Italy. umana.nch@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>29</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Pituitary</MedlineTA>
        <NlmUniqueID>9814578</NlmUniqueID>
        <ISSNLinking>1386-341X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Endocrine disorders</Keyword>
        <Keyword MajorTopicYN="N">Gamma knife</Keyword>
        <Keyword MajorTopicYN="N">Hypopituitarism</Keyword>
        <Keyword MajorTopicYN="N">Pituitary adenoma</Keyword>
        <Keyword MajorTopicYN="N">Radiation-induced complications</Keyword>
        <Keyword MajorTopicYN="N">Radiosurgery</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>29</Day>
          <Hour>12</Hour>
          <Minute>22</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35349010</ArticleId>
        <ArticleId IdType="doi">10.1007/s11102-022-01219-x</ArticleId>
        <ArticleId IdType="pii">10.1007/s11102-022-01219-x</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Musleh W, Sonabend M, A, Lesniak MS, (2006) Role of craniotomy in the management of pituitary adenomas and sellar/parasellar tumors. Expert Rev Anticancer Ther 6:S79–S83. https://doi.org/10.1586/14737140.6.9s.S79</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/14737140.6.9s.S79</ArticleId>
            <ArticleId IdType="pubmed">17004861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sheehan JP, Starke RM, Kano H et al (2014) Gamma Knife radiosurgery for sellar and parasellar meningiomas: a multicenter study. J Neurosurg 120:1268–1277. https://doi.org/10.3171/2014.2.JNS13139</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3171/2014.2.JNS13139</ArticleId>
            <ArticleId IdType="pubmed">24678777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kotecha R, Sahgal A, Rubens M et al (2020) Stereotactic radiosurgery for non-functioning pituitary adenomas: meta-analysis and International Stereotactic Radiosurgery Society practice opinion. Neuro Oncol 22:318–332. https://doi.org/10.1093/neuonc/noz225</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/neuonc/noz225</ArticleId>
            <ArticleId IdType="pubmed">31790121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee C-C, Sheehan JP (2016) Advances in gamma knife radiosurgery for pituitary tumors. Curr Opin Endocrinol Diabetes Obes 23:331–338. https://doi.org/10.1097/MED.0000000000000269</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MED.0000000000000269</ArticleId>
            <ArticleId IdType="pubmed">27341278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castinetti F, Régis J, Dufour H, Brue T (2010) Role of stereotactic radiosurgery in the management of pituitary adenomas. Nat Rev Endocrinol 6:214–223. https://doi.org/10.1038/nrendo.2010.4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrendo.2010.4</ArticleId>
            <ArticleId IdType="pubmed">20177403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X, Li Y, Cao Y et al (2017) Safety and efficacy of fractionated stereotactic radiotherapy and stereotactic radiosurgery for treatment of pituitary adenomas: a systematic review and meta-analysis. J Neurol Sci 372:110–116. https://doi.org/10.1016/j.jns.2016.11.024</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2016.11.024</ArticleId>
            <ArticleId IdType="pubmed">28017195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lunsford LD, Flickinger J, Lindner G, Maitz A (1989) Stereotactic radiosurgery of the brain using the first united states 201 cobalt-60 source gamma knife. Neurosurgery 24:151–159. https://doi.org/10.1227/00006123-198902000-00001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1227/00006123-198902000-00001</ArticleId>
            <ArticleId IdType="pubmed">2645538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benjamin C, Ashayeri K, Golfinos JG et al (2020) Treatment of sellar metastases with gamma knife radiosurgery in patients with advanced cancer. Pituitary 23:665–671. https://doi.org/10.1007/s11102-020-01074-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11102-020-01074-8</ArticleId>
            <ArticleId IdType="pubmed">32860552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cordeiro D, Xu Z, Mehta GU et al (2019) Hypopituitarism after gamma knife radiosurgery for pituitary adenomas: a multicenter, international study. J Neurosurg 131:1188–1196. https://doi.org/10.3171/2018.5.JNS18509</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3171/2018.5.JNS18509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Higham CE, Johannsson G, Shalet SM (2016) Hypopituitarism. Lancet 388:2403–2415. https://doi.org/10.1016/S0140-6736(16)30053-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(16)30053-8</ArticleId>
            <ArticleId IdType="pubmed">27041067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jasim S, Alahdab F, Ahmed AT et al (2017) Mortality in adults with hypopituitarism: a systematic review and meta-analysis. Endocrine 56:33–42. https://doi.org/10.1007/s12020-016-1159-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12020-016-1159-3</ArticleId>
            <ArticleId IdType="pubmed">27817141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Knappe UJ, Petroff D, Quinkler M et al (2020) Fractionated radiotherapy and radiosurgery in acromegaly: analysis of 352 patients from the German acromegaly registry. Eur J Endocrinol 182:275–284. https://doi.org/10.1530/EJE-19-0784</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/EJE-19-0784</ArticleId>
            <ArticleId IdType="pubmed">31917680</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cohen-Inbar O, Ramesh A, Xu Z et al (2016) Gamma knife radiosurgery in patients with persistent acromegaly or Cushing’s disease: long-term risk of hypopituitarism. Clin Endocrinol (Oxf) 84:524–531. https://doi.org/10.1111/cen.12938</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cen.12938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu J, Li Y, Quan T et al (2020) Initial gamma knife radiosurgery for nonfunctioning pituitary adenomas: results from a 26-year experience. Endocrine 68:399–410. https://doi.org/10.1007/s12020-020-02260-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12020-020-02260-1</ArticleId>
            <ArticleId IdType="pubmed">32162186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pekic S, Miljic D, Popovic V, et al (2021) Hypopituitarism Following Cranial Radiotherapy. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.</Citation>
        </Reference>
        <Reference>
          <Citation>Sicignano G, Losa M, del Vecchio A et al (2012) Dosimetric factors associated with pituitary function after gamma knife surgery (GKS) of pituitary adenomas. Radiother Oncol 104:119–124. https://doi.org/10.1016/j.radonc.2012.03.021</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.radonc.2012.03.021</ArticleId>
            <ArticleId IdType="pubmed">22647658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Starke RM, Williams BJ, Jane JA, Sheehan JP (2012) Gamma Knife surgery for patients with nonfunctioning pituitary macroadenomas: predictors of tumor control, neurological deficits, and hypopituitarism. J Neurosurg 117:129–135. https://doi.org/10.3171/2012.4.JNS112250</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3171/2012.4.JNS112250</ArticleId>
            <ArticleId IdType="pubmed">22577749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graffeo CS, Perry A, Link MJ et al (2021) Biological effective dose as a predictor of hypopituitarism after single-fraction pituitary adenoma radiosurgery: dosimetric analysis and cohort study of patients treated using contemporary techniques. Neurosurgery 88:E330–E335. https://doi.org/10.1093/neuros/nyaa555</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/neuros/nyaa555</ArticleId>
            <ArticleId IdType="pubmed">33469668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.n71</ArticleId>
            <ArticleId IdType="pubmed">8005924</ArticleId>
            <ArticleId IdType="pmc">8005924</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akabane A, Yamada S, Jokura H (2005) Gamma knife radiosurgery for pituitary adenomas. Endocrine 28:087–092. https://doi.org/10.1385/ENDO:28:1:087</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1385/ENDO:28:1:087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jeremy Howick, Iain Chalmers, Paul Glasziou, Trish Greenhalgh, Carl Heneghan, Alessandro Liberati, Ivan Moschetti, Bob Phillips and HT (2011) Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence (Background Document). In: Oxford Cent. Evidence-Based Med. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence . Accessed 20 Nov 2022.</Citation>
        </Reference>
        <Reference>
          <Citation>Joanna Briggs Institute (2020) Checklist for Case Series. https://jbi.global/critical-appraisal-tools . Accessed 20 Nov 2022.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson EB (1927) Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 22:209–212. https://doi.org/10.1080/01621459.1927.10502953</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/01621459.1927.10502953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Freeman MF, Tukey JW (1950) Transformations related to the angular and the square root. Ann Math Stat 21:607–611. https://doi.org/10.1214/aoms/1177729756</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1214/aoms/1177729756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188. https://doi.org/10.1016/0197-2456(86)90046-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId>
            <ArticleId IdType="pubmed">3802833</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Higgins JPT (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560. https://doi.org/10.1136/bmj.327.7414.557</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId>
            <ArticleId IdType="pubmed">12958120</ArticleId>
            <ArticleId IdType="pmc">12958120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Degerblad M, Rähn T, Bergstrand G, Thorén M (1986) Long-term results of stereotactic radiosurgery to the pituitary gland in Cushing’s disease. Acta Endocrinol (Copenh) 112:310–314. https://doi.org/10.1530/acta.0.1120310</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/acta.0.1120310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castinetti F, Nagai M, Morange I et al (2009) Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. J Clin Endocrinol Metab 94:3400–3407. https://doi.org/10.1210/jc.2008-2772</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2008-2772</ArticleId>
            <ArticleId IdType="pubmed">19509108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wan H, Chihiro O, Yuan S (2009) MASEP gamma knife radiosurgery for secretory pituitary adenomas: experience in 347 consecutive cases. J Exp Clin Cancer Res 28:36. https://doi.org/10.1186/1756-9966-28-36</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1756-9966-28-36</ArticleId>
            <ArticleId IdType="pubmed">19284583</ArticleId>
            <ArticleId IdType="pmc">2660297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marek J, Ježková J, Hána V et al (2011) Is it possible to avoid hypopituitarism after irradiation of pituitary adenomas by the Leksell gamma knife? Eur J Endocrinol 164:169–178. https://doi.org/10.1530/EJE-10-0733</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/EJE-10-0733</ArticleId>
            <ArticleId IdType="pubmed">21071488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee C-C, Kano H, Yang H-C et al (2014) Initial gamma knife radiosurgery for nonfunctioning pituitary adenomas. J Neurosurg 120:647–654. https://doi.org/10.3171/2013.11.JNS131757</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3171/2013.11.JNS131757</ArticleId>
            <ArticleId IdType="pubmed">24405068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hasegawa T, Shintai K, Kato T, Iizuka H (2015) Stereotactic radiosurgery as the initial treatment for patients with nonfunctioning pituitary adenomas. World Neurosurg 83:1173–1179. https://doi.org/10.1016/j.wneu.2015.01.054</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.wneu.2015.01.054</ArticleId>
            <ArticleId IdType="pubmed">25700971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gupta A, Xu Z, Kano H et al (2019) Upfront gamma knife radiosurgery for Cushing’s disease and acromegaly: a multicenter, international study. J Neurosurg 131:532–538. https://doi.org/10.3171/2018.3.JNS18110</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3171/2018.3.JNS18110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sims-Williams HP, Rajapaksa K, Sinha S et al (2019) Radiosurgery as primary management for acromegaly. Clin Endocrinol (Oxf) 90:114–121. https://doi.org/10.1111/cen.13870</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cen.13870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ježková J, Hána V, Kosák M et al (2019) Role of gamma knife radiosurgery in the treatment of prolactinomas. Pituitary 22:411–421. https://doi.org/10.1007/s11102-019-00971-x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11102-019-00971-x</ArticleId>
            <ArticleId IdType="pubmed">31222579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee WJ, Cho K-R, Choi J-W et al (2020) Gamma knife radiosurgery as a primary treatment for nonfunctioning pituitary adenoma invading the cavernous sinus. Stereotact Funct Neurosurg 98:371–377. https://doi.org/10.1159/000508737</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000508737</ArticleId>
            <ArticleId IdType="pubmed">32937617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y, Huang M, Liang S et al (2020) Gamma knife radiosurgery (GKRS) for patients with prolactinomas: long-term results from a single-center experience. Med Sci Monit 26:1–7</Citation>
        </Reference>
        <Reference>
          <Citation>Martinez R, Bravo G, Burzaco J, Rey G (1998) Pituitary tumors and gamma knife surgery - clinical experience with more than two years of follow-up. Stereotact Funct Neurosurg 70:110–118. https://doi.org/10.1159/000056413</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000056413</ArticleId>
            <ArticleId IdType="pubmed">9782242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mohammed N, Ding D, Hung Y et al (2020) Primary versus postoperative stereotactic radiosurgery for acromegaly: a multicenter matched cohort study. J Neurosurg 132:1507–1516. https://doi.org/10.3171/2019.1.JNS183398</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3171/2019.1.JNS183398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kara M, Yılmaz M, Şengöz M, Peker S (2021) Hormonal and radiologic outcomes after gamma knife radiosurgery for nonfunctioning pituitary adenomas. Br J Neurosurg. https://doi.org/10.1080/02688697.2021.1903388</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/02688697.2021.1903388</ArticleId>
            <ArticleId IdType="pubmed">33792443</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu Y, Wang M, Xu Y et al (2021) Comparing primary gamma knife radiosurgery and postoperative gamma knife radiosurgery for acromegaly: a monocenter retrospective study. Clin Neurol Neurosurg 200:106385. https://doi.org/10.1016/j.clineuro.2020.106385</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clineuro.2020.106385</ArticleId>
            <ArticleId IdType="pubmed">33290886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, Chen W, Ding C et al (2021) Gamma knife radiosurgery as the initial treatment for elderly patients with nonfunctioning pituitary adenomas. J Neurooncol 152:257–264. https://doi.org/10.1007/s11060-021-03724-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11060-021-03724-8</ArticleId>
            <ArticleId IdType="pubmed">33638114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim YL, Leem W, Kim TS et al (1998) Four years’ experiences in the treatment of pituitary adenomas with gamma knife radiosurgery. Stereotact Funct Neurosurg 70:95–109. https://doi.org/10.1159/000056412</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000056412</ArticleId>
            <ArticleId IdType="pubmed">9782241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan L, Zhang N, Wang EM et al (2000) Gamma knife radiosurgery as a primary treatment for prolactinomas. J Neurosurg 93(Suppl 3):10–13. https://doi.org/10.3171/jns.2000.93.supplement</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3171/jns.2000.93.supplement</ArticleId>
            <ArticleId IdType="pubmed">11143223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang N, Pan L, Wang EM et al (2000) Radiosurgery for growth hormone—producing pituitary adenomas. J Neurosurg 93:6–9. https://doi.org/10.3171/jns.2000.93.supplement_3.0006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3171/jns.2000.93.supplement_3.0006</ArticleId>
            <ArticleId IdType="pubmed">11143264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Höybye C, Grenbäck E, Rähn T et al (2001) Adrenocorticotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery. Neurosurgery 49:284–292. https://doi.org/10.1097/00006123-200108000-00008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00006123-200108000-00008</ArticleId>
            <ArticleId IdType="pubmed">11504104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi JY, Chang JH, Chang JW et al (2003) Radiological and Hormonal responses of functioning pituitary adenomas after γ knife radiosurgery. Yonsei Med J 44:602. https://doi.org/10.3349/ymj.2003.44.4.602</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3349/ymj.2003.44.4.602</ArticleId>
            <ArticleId IdType="pubmed">12950114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vladyka V, Liščák R, Novotný J et al (2003) Radiation tolerance of functioning pituitary tissue in gamma knife surgery for pituitary adenomas. Neurosurgery 52:309–317. https://doi.org/10.1227/01.NEU.0000043709.53906.31</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1227/01.NEU.0000043709.53906.31</ArticleId>
            <ArticleId IdType="pubmed">12535358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim M, Paeng S, Pyo S et al (2006) Gamma knife surgery for invasive pituitary macroadenoma. J Neurosurg 105:26–30. https://doi.org/10.3171/sup.2006.105.7.26</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3171/sup.2006.105.7.26</ArticleId>
            <ArticleId IdType="pubmed">18503326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Albano L, Losa M, Barzaghi LR et al (2021) Gamma knife radiosurgery for pituitary tumors: a systematic review and meta-analysis. Cancers (Basel) 13:4998. https://doi.org/10.3390/cancers13194998</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cancers13194998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gittleman H, Ostrom QT, Farah PD et al (2014) Descriptive epidemiology of pituitary tumors in the United States, 2004–2009. J Neurosurg 121:527–535. https://doi.org/10.3171/2014.5.JNS131819</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3171/2014.5.JNS131819</ArticleId>
            <ArticleId IdType="pubmed">24926650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castellanos LE, Gutierrez C, Smith T et al (2017) Epidemiology of common and uncommon adult pituitary tumors in the U.S. according to the, World Health Organization classification. Pituitary. https://doi.org/10.1007/s11102-021-01189-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11102-021-01189-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Melmed S (2020) Pituitary-tumor endocrinopathies. N Engl J Med 382:937–950. https://doi.org/10.1056/NEJMra1810772</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMra1810772</ArticleId>
            <ArticleId IdType="pubmed">32130815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khan DZ, Luengo I, Barbarisi S et al (2021) Automated operative workflow analysis of endoscopic pituitary surgery using machine learning: development and preclinical evaluation (IDEAL stage 0). J Neurosurg. https://doi.org/10.3171/2021.6.JNS21923</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3171/2021.6.JNS21923</ArticleId>
            <ArticleId IdType="pubmed">35099915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ammirati M, Wei L, Ciric I (2013) Short-term outcome of endoscopic versus microscopic pituitary adenoma surgery: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 84:843–849. https://doi.org/10.1136/jnnp-2012-303194</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp-2012-303194</ArticleId>
            <ArticleId IdType="pubmed">23243265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palmisciano P, Haider AS, Sabahi M et al (2021) Primary skull base chondrosarcomas: a systematic review. Cancers (Basel) 13:5960. https://doi.org/10.3390/cancers13235960</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cancers13235960</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palmisciano P, El Ahmadieh TY, Haider AS et al (2021) Thalamic gliomas in adults: a systematic review of clinical characteristics, treatment strategies, and survival outcomes. J Neurooncol 155:215–224. https://doi.org/10.1007/s11060-021-03898-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11060-021-03898-1</ArticleId>
            <ArticleId IdType="pubmed">34797525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim CT, Korbonits MK (2018) Update on the clinicopathology of pituitary adenomas. Endocr Pract 24:473–488. https://doi.org/10.4158/EP-2018-0034</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4158/EP-2018-0034</ArticleId>
            <ArticleId IdType="pubmed">29498920</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oh JW, Sung KS, Moon JH et al (2018) Hypopituitarism after gamma knife surgery for postoperative nonfunctioning pituitary adenoma. J Neurosurg 129:47–54. https://doi.org/10.3171/2018.7.GKS181589</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3171/2018.7.GKS181589</ArticleId>
            <ArticleId IdType="pubmed">30544293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nomikos P, Ladar C, Fahlbusch R, Buchfelder M (2004) Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas ? A study on 721 patients. Acta Neurochir (Wien) 146:27–35. https://doi.org/10.1007/s00701-003-0174-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00701-003-0174-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nomikos P, Buchfelder M, Fahlbusch R (2005) The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ‘cure.’ Eur J Endocrinol 152:379–387. https://doi.org/10.1530/eje.1.01863</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/eje.1.01863</ArticleId>
            <ArticleId IdType="pubmed">15757854</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fatemi N, Dusick JR, Mattozo C et al (2008) Pituitary hormonal loss and recovery after transsphenoidal adenoma removal. Neurosurgery 63:709–718</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1227/01.NEU.0000325725.77132.90</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Estrada J, Boronat M, Mielgo M et al (1997) The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing’s disease. N Engl J Med 336:172–177. https://doi.org/10.1056/NEJM199701163360303</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM199701163360303</ArticleId>
            <ArticleId IdType="pubmed">8988897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darzy KH (2009) Radiation-induced hypopituitarism after cancer therapy: who, how and when to test. Nat Clin Pract Endocrinol Metab 5:88–99. https://doi.org/10.1038/ncpendmet1051</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncpendmet1051</ArticleId>
            <ArticleId IdType="pubmed">19165221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh R, Didwania P, Lehrer EJ et al (2020) Stereotactic radiosurgery for acromegaly: an international systematic review and meta-analysis of clinical outcomes. J Neurooncol 148:401–418. https://doi.org/10.1007/s11060-020-03552-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11060-020-03552-2</ArticleId>
            <ArticleId IdType="pubmed">32506372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castinetti F, Morange I, Dufour H et al (2009) Radiotherapy and radiosurgery in acromegaly. Pituitary 12:3–10. https://doi.org/10.1007/s11102-007-0078-y</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11102-007-0078-y</ArticleId>
            <ArticleId IdType="pubmed">18175223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamada S, Vidal S, Sano T et al (2003) Effect of gamma knife radiosurgery on a pituitary gonadotroph adenoma: a histologic, immunohistochemical and electron microscopic study. Pituitary 6:53–58. https://doi.org/10.1023/a:1026238028623</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/a:1026238028623</ArticleId>
            <ArticleId IdType="pubmed">14674725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palmisciano P, Haider AS, Nwagwu CD et al (2021) Bevacizumab vs laser interstitial thermal therapy in cerebral radiation necrosis from brain metastases: a systematic review and meta-analysis. J Neurooncol 154:13–23. https://doi.org/10.1007/s11060-021-03802-x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11060-021-03802-x</ArticleId>
            <ArticleId IdType="pubmed">34218396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pomeraniec IJ, Xu Z, Lee C-C et al (2021) Dose to neuroanatomical structures surrounding pituitary adenomas and the effect of stereotactic radiosurgery on neuroendocrine function: an international multicenter study. J Neurosurg. https://doi.org/10.3171/2021.3.JNS203812</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3171/2021.3.JNS203812</ArticleId>
            <ArticleId IdType="pubmed">34560630</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iwata H, Sato K, Nomura R et al (2016) Long-term results of hypofractionated stereotactic radiotherapy with cyberknife for growth hormone-secreting pituitary adenoma: evaluation by the Cortina consensus. J Neurooncol 128:267–275. https://doi.org/10.1007/s11060-016-2105-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11060-016-2105-1</ArticleId>
            <ArticleId IdType="pubmed">26961771</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barone F, Inserra F, Scalia G et al (2021) 68Ga-DOTATOC PET/CT follow up after single or hypofractionated gamma knife ICON radiosurgery for meningioma patients. Brain Sci 11:375. https://doi.org/10.3390/brainsci11030375</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/brainsci11030375</ArticleId>
            <ArticleId IdType="pubmed">33804251</ArticleId>
            <ArticleId IdType="pmc">8001061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferini G, Viola A, Valenti V et al (2022) Whole brain irradiation or stereotactic radiosurgery for five or more brain metastases (WHOBI-STER): a prospective comparative study of neurocognitive outcomes, level of autonomy in daily activities and quality of life. Clin Transl Radiat Oncol 32:52–58. https://doi.org/10.1016/j.ctro.2021.11.008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ctro.2021.11.008</ArticleId>
            <ArticleId IdType="pubmed">34926839</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
